We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
About this guideline
Overseas effective date: 30 Aug 2001
Categories: Biological medicines | Drug substance | Plasma-derived medicinal products
Access this international scientific guideline
TGA annotations
Annex V (CPMP/BWP/390/97) of Guidance CPMP/BWP/269/95 Rev 3 remains current.
Further information: Replaced by: EMA/CHMP/BWP/706271/2010
For more information see International scientific guidelines adopted in Australia.
Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.